Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13G Filing: Nokomis Capital and Transatlantic Petroleum Ltd. (TAT)

Page 1 of 7

Brett Hendrickson’s Nokomis Capital disclosed a 10.3% position in Transatlantic Petroleum Ltd. (TAT) in a 13G filing. At the end of the third quarter, Nokomis Capital held 2.18 million shares of the company valued at $5.5 million at the end of September. You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Nokomis Capital, L.L.C. 0 4,394,083 0 4,394,083 10.3%
Brett Hendrickson 0 4,394,083 0 4,394,083 10.3%
Brett Hendrickson
Brett Hendrickson
Nokomis Capital

Page 1 of 7 SEC Filing

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

SCHEDULE 13G

(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO

RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED

PURSUANT TO RULE 13d-2(b)

 

 

TransAtlantic
Petroleum Ltd.

(Name of Issuer)

Common shares, par value $0.10

(Title of Class of Securities)

G89982113

(CUSIP Number)

December 31, 2015

(Date of Event Which Requires Filing of this Statement)

 

 

Check the appropriate box to
designate the rule pursuant to which this Schedule is filed:

x Rule 13d-1(b)

¨ Rule 13d-1(c)

¨ Rule 13d-1(d)

Follow Transatlantic Petroleum Ltd. (NYSEMKT:TAT)
Trade (NYSEMKT:TAT) Now!
Page 1 of 7

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!